Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026 (Event date: September 2, 2026)
Context: The filing incorporates by reference a press release regarding the exercise of warrants by investors.
Key Financial Metrics
Capital Raised: Approximately $4.0 million in gross proceeds from warrant exercises.
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics. This report focuses solely on the capital event.
Material Changes
The primary material change is the increase in cash resources resulting from the exercise of warrants. No comparative financial data or changes in operational metrics versus prior periods are disclosed in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release titled "Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds" but does not include the full text of the commentary, outlook, or risk factors within the body of the 6-K form itself.
Unusual Items: None reported beyond the warrant exercise event.
Investor Verification Checklist
- Verify the exact number of warrants exercised and the exercise price per warrant.
- Confirm the post-transaction share count and potential dilution impact.
- Review the full text of the press release (Exhibit 99.1) for details on the use of proceeds.
- Check subsequent filings for updated cash balance and liquidity position.